查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604586

抗毒素市场：按物种/类型 - 2025-2030 年全球预测

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗毒素市值为26.9亿美元，预计2024年将达28.7亿美元，复合年增长率为7.17%，预计2030年将达43.7亿美元。

抗蛇毒血清市场对于治疗蛇、蜘蛛、蝎子和其他有毒生物的毒咬伤和螫伤至关重要，并且在医疗保健、野生动物保护甚至军事准备等领域也至关重要。在非洲、亚洲和拉丁美洲部分地区，与有毒动物频繁接触的地区迫切需要抗毒素，以拯救生命并预防严重併发症。应用范围包括医院、诊所和现场工作，这对紧急医疗团队来说至关重要。最终用途包括医疗机构、研究机构和实施公共卫生倡议的政府。抗蛇毒血清市场的关键成长要素包括全球毒液咬伤发生率上升、医疗基础设施投资增加以及人们对抗蛇毒血清治疗的可用性和需求的认识不断提高。基因组学和生物技术的技术进步也在扩大产品创新，并为开发更安全、更有效的抗蛇毒血清提供了机会。然而，市场面临生产成本高、监管要求严格、动物毒素产量波动导致供需失衡等挑战。此外，某些地区的认知度低也限制了市场的成长。公司可以透过投资重组技术和探索单株抗体和合成胜肽等多样化平台来进行创新。频谱抗蛇毒血清的研究是降低生产成本和提高功效的一个有前景的领域。与高风险地区的医疗保健提供者建立伙伴关係可以加强您的分销网络并提高市场渗透率。该市场本质上是利基市场，但随着研究对毒液和抗毒素製剂的性质产生新的见解，该市场不断扩大。重点还应放在提高当地生产能力以应对出口限制并减少对特定毒液来源的依赖，最终降低成本并提高可用性。随着市场的发展，利用这些成长路径将有助于确保业务扩张并巩固我们作为挽救生命的医疗保健解决方案领导者的地位。

主要市场统计
基准年[2023] 26.9亿美元
预计年份 [2024] 28.7亿美元
预测年份 [2030] 43.7亿美元
复合年增长率（%） 7.17%

市场动态：揭示快速发展的抗毒素市场的关键市场洞察

供需的动态交互作用正在改变抗蛇毒血清市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 蛇咬伤案例增加
    • 提高对可用作急救治疗的抗蛇毒血清的认识
    • 加大农村地区医疗卫生基础建设力度
  • 市场限制因素
    • 抗蛇毒血清生产成本高
  • 市场机会
    • 抗毒素生产技术进步
    • 改善各国的抗毒素分销网络
  • 市场挑战
    • 缺乏抗蛇毒血清生产的监管标准

波特的五力：驾驭抗毒素市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗毒素市场的外部影响

外部宏观环境因素在塑造抗毒素市场的表现动态中发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗毒素市场的竞争格局

对抗毒素市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗毒素市场供应商的绩效评估

FPNV定位矩阵是评估抗毒素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製抗毒素市场的成功之路

抗毒素市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 蛇咬伤事件增加
      • 提高对可用于紧急医疗护理的抗毒素的认识
      • 改善当地医疗基础设施的进展
    • 抑制因素
      • 抗毒素生产成本高
    • 机会
      • 抗毒素生产技术进步
      • 改善各国的抗毒素分销网络
    • 任务
      • 缺乏抗蛇毒血清生产的监管标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 抗毒素市场：类型

  • 蝎
  • 蛇
  • 蜘蛛

第七章抗毒素市场：依类型

  • 单价抗毒素
  • 多效价抗毒素

第八章美洲抗毒素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太抗毒素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲抗毒素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amsaal LLC
  • BB-NCIPD Ltd.
  • Bharat Serums and Vaccines Limited（BSV）
  • Boehringer Ingelheim International GmbH.
  • BTG International Inc.
  • Creative BioMart
  • CSL
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Incepta Pharma
  • Inosan Biopharma
  • Institute of Vaccines and Medical Biologicals
  • Instituto Clodomiro Picado
  • KM Biologics
  • Laboratorios Silanes, SA de CV
  • Lexicare Pharma Pvt. Ltd.
  • Medtoxin Venom Laboratories, LLC
  • Merck & Co., Inc.
  • MicroPharm
  • Padula Serums Pty Ltd.
  • Pfizer Inc.
  • Rare Disease Therapeutics, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Shanghai Serum Bio-technology Co., Ltd.
  • VINS Bioproducts Ltd.
Product Code: MRR-C002B1C99489

The Antivenoms Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.87 billion in 2024, and is projected to grow at a CAGR of 7.17%, to USD 4.37 billion by 2030.

The antivenoms market is crucial for treating venomous bites and stings from snakes, spiders, scorpions, and other venomous creatures, making it vital for areas like healthcare, wildlife conservation, and even military preparedness. Antivenoms are urgently necessary in regions with high incidences of venomous animal encounters, such as parts of Africa, Asia, and Latin America, where they save lives and prevent serious complications. Application areas include hospitals, clinics, and field operations, and they are essential for emergency medical teams. The scope of end-use extends to healthcare facilities, research institutions, and governments implementing public health initiatives. Key growth factors in the antivenom market include the rising incidence of venomous bites worldwide, growing investments in healthcare infrastructure, and increasing awareness about the availability and necessity of antivenom treatments. Technological advancements in genomics and biotechnology are also expanding product innovation, offering opportunities to develop safer, more effective antivenoms. However, the market faces challenges such as high production costs, stringent regulatory requirements, and supply-demand imbalances exacerbated by fluctuating animal venom yields. Limited awareness in certain regions also constrains market growth. Organizations can innovate by investing in recombinant technology and exploring diversified platforms like monoclonal antibodies or synthetic peptide antivenoms. Research into broad-spectrum antivenoms is a promising area for reducing manufacturing costs and improving efficacy. Establishing partnerships with local healthcare providers in high-risk regions can enhance distribution networks and market penetration. The nature of the market is niche but expanding, as research provides new insights into venom properties and antivenom formulations. Emphasis should also be on boosting local production capabilities to combat export restrictions and reducing dependency on specific venom sources, ultimately driving down costs and improving accessibility. As the market evolves, tapping into these growth avenues can secure business expansion and solidify a company's standing as a leader in lifesaving healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.87 billion
Forecast Year [2030] USD 4.37 billion
CAGR (%) 7.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antivenoms Market

The Antivenoms Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of snake bites
    • Rising awareness of antivenoms available as first-aid
    • Increasing improvements in healthcare infrastructure in rural areas
  • Market Restraints
    • High production cost of antivenoms
  • Market Opportunities
    • Technical advancements in antivenoms production
    • Improvement in distribution networks of antivenoms in countries
  • Market Challenges
    • Lack of regulatory norms for antivenom manufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Antivenoms Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antivenoms Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antivenoms Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antivenoms Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antivenoms Market

A detailed market share analysis in the Antivenoms Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antivenoms Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antivenoms Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antivenoms Market

A strategic analysis of the Antivenoms Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..

Market Segmentation & Coverage

This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Species, market is studied across Scorpion, Snakes, and Spiders.
  • Based on Type, market is studied across Monovalent Antivenom and Polyvalent Antivenom.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of snake bites
      • 5.1.1.2. Rising awareness of antivenoms available as first-aid
      • 5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost of antivenoms
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancements in antivenoms production
      • 5.1.3.2. Improvement in distribution networks of antivenoms in countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory norms for antivenom manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antivenoms Market, by Species

  • 6.1. Introduction
  • 6.2. Scorpion
  • 6.3. Snakes
  • 6.4. Spiders

7. Antivenoms Market, by Type

  • 7.1. Introduction
  • 7.2. Monovalent Antivenom
  • 7.3. Polyvalent Antivenom

8. Americas Antivenoms Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antivenoms Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antivenoms Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amsaal LLC
  • 2. BB - NCIPD Ltd.
  • 3. Bharat Serums and Vaccines Limited (BSV)
  • 4. Boehringer Ingelheim International GmbH.
  • 5. BTG International Inc.
  • 6. Creative BioMart
  • 7. CSL
  • 8. Haffkine Bio-Pharmaceutical Corporation Ltd.
  • 9. Incepta Pharma
  • 10. Inosan Biopharma
  • 11. Institute of Vaccines and Medical Biologicals
  • 12. Instituto Clodomiro Picado
  • 13. KM Biologics
  • 14. Laboratorios Silanes, S.A. de C.V
  • 15. Lexicare Pharma Pvt. Ltd.
  • 16. Medtoxin Venom Laboratories, LLC
  • 17. Merck & Co., Inc.
  • 18. MicroPharm
  • 19. Padula Serums Pty Ltd.
  • 20. Pfizer Inc.
  • 21. Rare Disease Therapeutics, Inc.
  • 22. Serum Institute of India Pvt. Ltd.
  • 23. Shanghai Serum Bio-technology Co., Ltd.
  • 24. VINS Bioproducts Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIVENOMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIVENOMS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIVENOMS MARKET SIZE, BY SCORPION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIVENOMS MARKET SIZE, BY SNAKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIVENOMS MARKET SIZE, BY SPIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIVENOMS MARKET SIZE, BY MONOVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIVENOMS MARKET SIZE, BY POLYVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023